.png)
Sickle Cell Anemia Testing & Screening Market Technologies (Hemoglobin Electrophoresis, High-performance Liquid Chromatography, Point-of-Care Tests, Other Tests), Age Groups (Newborn Screening - 12 months and Below, Adult Screening - 25 years to 60 years, & Other Age Groups - 1 year to 25 years & Above 60 years), Sector Types (Government Labs, Private Labs, Corporate Labs, and Public-Private-Partnerships (PPP)) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast to 2023 – 2031
Published On : July 2022 Pages : 145 Category: Pharma & Healthcare Report Code : HC1217819
SEGMENTS & REGIONS:
- Technologies: Hemoglobin Electrophoresis, High-performance Liquid Chromatography, Point-of-Care Tests, Other Tests
- Age Groups: Newborn Screening - 12 months and Below, Adult Screening - 25 years to 60 years, & Other Age Groups - 1 year to 25 years & Above 60 years
- Sector Types: Government Labs, Private Labs, Corporate Labs, and Public-Private-Partnerships (PPP
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
The Sickle Cell Anemia Testing and Screening Market is a specialized segment of the healthcare diagnostics market focused on providing testing and screening services for sickle cell anemia. Here's a detailed overview:
Market Overview
- Market Size: The global sickle cell anemia testing and screening market was valued at approximately USD 425.7 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 12.1% from 2025 to 2030.
- Key Drivers: The market is driven by the increasing global prevalence of sickle cell anemia, especially in high-risk regions, and the growing demand for early diagnosis and testing. Advancements in diagnostic technologies, such as genetic testing and PCR, have made screenings more accurate, faster, and cost-effective1.
Market Segmentation
- By Technology: Hemoglobin Electrophoresis, Point-of-Care Tests, Genetic Testing, High-Performance Liquid Chromatography (HPLC)
- By Age Group: Newborn Screening, Ages 1 to 25, Ages 26 and Above
- By Sector Type: Government Labs, Private Labs, Corporate Labs, Public-Private Partnerships (PPP)
- By Region: North America, Latin America, Asia Pacific, Europe, Middle East, Africa
Key Applications
- Hemoglobin Electrophoresis: This technique is highly accurate in identifying hemoglobin variants and is considered the gold standard for sickle cell screening.
- Point-of-Care Tests: These tests provide quick and accessible screening options, especially useful in remote and resource-limited settings.
- Genetic Testing: Advanced genetic tests offer precise diagnosis and are increasingly being adopted for early detection.
- Newborn Screening: Early detection programs for newborns are crucial for timely intervention and improved health outcomes.
Market Trends
- Technological Advancements: Continuous improvements in diagnostic technologies have made testing more accurate, faster, and cost-effective.
- Government Initiatives: Public health campaigns and newborn screening programs are driving the adoption of testing services.
- Noninvasive Techniques: Portable screening tools and noninvasive diagnostic techniques are enabling early detection, even in remote areas.
Regional Insights
- Asia Pacific: Rapidly growing market driven by increasing awareness and healthcare initiatives.
- North America: Leading the market due to advanced healthcare infrastructure and high prevalence of sickle cell anemia.
The sickle cell anemia testing and screening market is poised for substantial growth, driven by the rising demand for advanced and non-invasive diagnostic options. This market offers significant opportunities for companies to innovate and expand their offerings to meet the evolving needs of healthcare providers and patients.
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Data Mining
1.2.2. Market Modeling and Forecasting
1.2.3. Data Validation
1.2.4. Industry Analysis
2. Market Dashboard
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
4. SWOT Analysis
5. Porter’s Five Forces Analysis
5.1.1. Competitive Rivalry
5.1.2. Threat of New Entrants
5.1.3. Bargaining Power of Suppliers
5.1.4. Bargaining Power of Buyers
5.1.5. Threat of Substitute Products
6. PESTEL Analysis
6.1.1. Political Factors
6.1.2. Economical Factors
6.1.3. Technological Factors
6.1.4. Environmental Factors
6.1.5. Legal Factors
7. Sickle Cell Anemia Testing And Screening Market, By Technologies
7.1. Introduction
7.2. Sickle Cell Anemia Testing And Screening Market and Market Growth Rate By Technologies (2019-2030)
7.3. Hemoglobin Electrophoresis
7.3.1. Global Hemoglobin Electrophoresis Market and Growth Rate (2019-2030)
7.4. High-performance Liquid Chromatography
7.4.1. Global High-performance Liquid Chromatography Market and Growth Rate (2019-2030)
7.5. Point-of-Care Tests
7.5.1. Global Point-of-Care Tests Market and Growth Rate (2019-2030)
7.6. Others
7.6.1. Global Others Market and Growth Rate (2019-2030)
8. Sickle Cell Anemia Testing And Screening Market, By Age Groups
8.1. Introduction
8.2. Sickle Cell Anemia Testing And Screening Market and Market Growth Rate By Age Groups (2019-2030)
8.3. Newborn Screening (12 months and Below)
8.3.1. Global Newborn Screening (12 months and Below) Market and Growth Rate (2019-2030)
8.4. Adult Screening (25 years to 60 years)
8.4.1. Global Adult Screening (25 years to 60 years) Market and Growth Rate (2019-2030)
8.5. Other Age Groups (1 year to 25 years & Above 60 years)
8.5.1. Global Other Age Groups (1 year to 25 years & Above 60 years) Market and Growth Rate (2019-2030)
9. Sickle Cell Anemia Testing And Screening Market, By Sector Type
9.1. Introduction
9.2. Sickle Cell Anemia Testing And Screening Market and Market Growth Rate By Sector Type (2019-2030)
9.3. Government Labs
9.3.1. Global Government Labs Market and Growth Rate (2019-2030)
9.4. Private Labs
9.4.1. Global Private Labs Market and Growth Rate (2019-2030)
9.5. Corporate Labs
9.5.1. Global Corporate Labs Market and Growth Rate (2019-2030)
9.6. Public-Private-Partnerships (PPP)
9.6.1. Global Public-Private-Partnerships (PPP) Market and Growth Rate (2019-2030)
10. Sickle Cell Anemia Testing And Screening Market, By Region
10.1. Introduction
10.2. Sickle Cell Anemia Testing And Screening Market and Growth Rate By Regions
10.3. North America
10.3.1. North America Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030))
10.3.2. North America Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.3.3. North America Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.3.4. North America Sickle Cell Anemia Testing And Screening Market By Country (2019-2030)
10.3.5. United States
10.3.5.1. United States Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030)
10.3.5.2. United States Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.3.5.3. United States Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.3.6. Canada
10.3.6.1. Canada Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030)
10.3.6.2. Canada Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.3.6.3. Canada Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.4. Europe
10.4.1. Europe Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030))
10.4.2. Europe Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.4.3. Europe Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.4.4. Europe Sickle Cell Anemia Testing And Screening Market By Country (2019-2030)
10.4.5. Germany
10.4.5.1. Germany Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030)
10.4.5.2. Germany Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.4.5.3. Germany Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.4.6. France
10.4.6.1. France Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030)
10.4.6.2. France Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.4.6.3. France Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.4.7. UK
10.4.7.1. UK Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030)
10.4.7.2. UK Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.4.7.3. UK Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.4.8. Russia
10.4.8.1. Russia Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030)
10.4.8.2. Russia Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.4.8.3. Russia Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.4.9. Italy
10.4.9.1. Italy Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030)
10.4.9.2. Italy Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.4.9.3. Italy Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.4.10. Rest of Europe
10.4.10.1. Rest of Europe Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030)
10.4.10.2. Rest of Europe Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.4.10.3. Rest of Europe Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.5. Asia-Pacific
10.5.1. Asia-Pacific Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030))
10.5.2. Asia-Pacific Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.5.3. Asia-Pacific Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.5.4. Asia-Pacific Sickle Cell Anemia Testing And Screening Market By Country (2019-2030)
10.5.5. China
10.5.5.1. China Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030)
10.5.5.2. China Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.5.5.3. China Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.5.6. Japan
10.5.6.1. Japan Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030)
10.5.6.2. Japan Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.5.6.3. Japan Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.5.7. Korea
10.5.7.1. Korea Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030)
10.5.7.2. Korea Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.5.7.3. Korea Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.5.8. India
10.5.8.1. India Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030)
10.5.8.2. India Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.5.8.3. India Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.5.9. Southeast Asia
10.5.9.1. Southeast Asia Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030)
10.5.9.2. Southeast Asia Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.5.9.3. Southeast Asia Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.5.10. Rest of Asia-Pacific
10.5.10.1. Rest of Asia-Pacific Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030)
10.5.10.2. Rest of Asia-Pacific Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.5.10.3. Rest of Asia-Pacific Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.6. South America
10.6.1. South America Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030))
10.6.2. South America Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.6.3. South America Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.6.4. South America Sickle Cell Anemia Testing And Screening Market By Country (2019-2030)
10.6.5. Brazil
10.6.5.1. Brazil Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030)
10.6.5.2. Brazil Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.6.5.3. Brazil Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.6.6. Mexico
10.6.6.1. Mexico Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030)
10.6.6.2. Mexico Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.6.6.3. Mexico Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.6.7. Columbia
10.6.7.1. Columbia Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030)
10.6.7.2. Columbia Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.6.7.3. Columbia Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.6.8. Rest of South America
10.6.8.1. Rest of South America Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030)
10.6.8.2. Rest of South America Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.6.8.3. Rest of South America Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.7. Middle East and Africa
10.7.1. Middle East and Africa Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030))
10.7.2. Middle East and Africa Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.7.3. Middle East and Africa Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.7.4. Middle East and Africa Sickle Cell Anemia Testing And Screening Market By Country (2019-2030)
10.7.5. Saudi Arabia
10.7.5.1. Saudi Arabia Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030)
10.7.5.2. Saudi Arabia Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.7.5.3. Saudi Arabia Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.7.6. United Arab Emirates
10.7.6.1. United Arab Emirates Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030)
10.7.6.2. United Arab Emirates Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.7.6.3. United Arab Emirates Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.7.7. South Africa
10.7.7.1. South Africa Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030)
10.7.7.2. South Africa Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.7.7.3. South Africa Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
10.7.8. Rest of Middle East and Africa
10.7.8.1. Rest of Middle East and Africa Sickle Cell Anemia Testing And Screening Market and Growth Rate (2019-2030)
10.7.8.2. Rest of Middle East and Africa Sickle Cell Anemia Testing And Screening Market By Type (2019-2030)
10.7.8.3. Rest of Middle East and Africa Sickle Cell Anemia Testing And Screening Market By Application (2019-2030)
11. Company Profiles
11.1. HemoTypeSC
11.1.1. Business Overview
11.1.2. Service Portfolio
11.1.3. Strategic Developments
11.1.4. Financial Overview
11.2. Halcyon Biomedical, Inc.
11.2.1. Business Overview
11.2.2. Service Portfolio
11.2.3. Strategic Developments
11.2.4. Financial Overview
11.3. Request A Test, Ltd
11.3.1. Business Overview
11.3.2. Service Portfolio
11.3.3. Strategic Developments
11.3.4. Financial Overview
11.4. Daktari Diagnostics
11.4.1. Business Overview
11.4.2. Service Portfolio
11.4.3. Strategic Developments
11.4.4. Financial Overview
11.5. Streck, Inc.
11.5.1. Business Overview
11.5.2. Service Portfolio
11.5.3. Strategic Developments
11.5.4. Financial Overview
11.6. Bio-Rad Laboratories, Inc
11.6.1. Business Overview
11.6.2. Service Portfolio
11.6.3. Strategic Developments
11.6.4. Financial Overview
11.7. Hemex Health
11.7.1. Business Overview
11.7.2. Service Portfolio
11.7.3. Strategic Developments
11.7.4. Financial Overview
11.8. Silver Lake Research Corporation
11.8.1. Business Overview
11.8.2. Service Portfolio
11.8.3. Strategic Developments
11.8.4. Financial Overview
11.9. BioMedomics Inc.
11.9.1. Business Overview
11.9.2. Service Portfolio
11.9.3. Strategic Developments
11.9.4. Financial Overview
11.10. Laboratory Corporation of America Holdings
11.10.1. Business Overview
11.10.2. Service Portfolio
11.10.3. Strategic Developments
11.10.4. Financial Overview
12. List of Tables and Figures
Figure United States Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2022-2027)
Figure Canada Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2022-2027)
Figure Germany Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2022-2027)
Figure France Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2022-2027)
Figure UK Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2022-2027)
Figure Russia Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2022-2027)
Figure Italy Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2022-2027)
Figure Rest of Europe Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2022-2027)
Figure China Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2022-2027)
Figure Japan Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2022-2027)
Figure Korea Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2022-2027)
Figure India Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2022-2027)
Figure Southeast Asia Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2022-2027)
Figure Rest of Asia-Pacific Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2022-2027)
Figure Brazil Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2022-2027)
Figure Mexico Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2022-2027)
Figure Columbia Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2022-2027)
Figure Rest of South America Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2022-2027)
Figure Saudi Arabia Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2022-2027)
Figure United Arab Emirates Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2022-2027)
Figure South Africa Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2022-2027)
Figure Rest of Middle East and Africa Sickle Cell Anemia Testing And Screening Revenue (Million USD) and Growth Rate (2022-2027)
Table Sickle Cell Anemia Testing And Screening Market and Market Share by Technologies (2022-2027)
Figure Hemoglobin Electrophoresis Market and Growth Rate (2022-2027)
Figure High-performance Liquid Chromatography Market and Growth Rate (2022-2027)
Figure Point-of-Care Tests Market and Growth Rate (2022-2027)
Figure Others Market and Growth Rate (2022-2027)
Table Sickle Cell Anemia Testing And Screening Market and Market Share by Age Groups (2022-2027)
Figure Newborn Screening (12 months and Below) Market and Growth Rate (2022-2027)
Figure Adult Screening (25 years to 60 years) Market and Growth Rate (2022-2027)
Figure Other Age Groups (1 year to 25 years & Above 60 years) Market and Growth Rate (2022-2027)
Table Sickle Cell Anemia Testing And Screening Market and Market Share by Sector Type (2022-2027)
Figure Government Labs Market and Growth Rate (2022-2027)
Figure Private Labs Market and Growth Rate (2022-2027)
Figure Corporate Labs Market and Growth Rate (2022-2027)
Figure Public-Private-Partnerships (PPP) Market and Growth Rate (2022-2027)
Table Sickle Cell Anemia Testing And Screening Market by Regions (2022-2027)
Figure North America Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure North America Sickle Cell Anemia Testing And Screening Market and Growth Rate (2022-2027)
Figure North America Sickle Cell Anemia Testing And Screening by Country (2022-2027)
Figure North America Sickle Cell Anemia Testing And Screening Revenue (Million USD) by Country (2022-2027)
Figure United States Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure United States Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2022-2027)
Figure Canada Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure Canada Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2022-2027)
Figure Europe Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure Europe Sickle Cell Anemia Testing And Screening Market and Growth Rate (2022-2027)
Figure Europe Sickle Cell Anemia Testing And Screening by Country (2022-2027)
Figure Europe Sickle Cell Anemia Testing And Screening Revenue (Million USD) by Country (2022-2027)
Figure Germany Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure Germany Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2022-2027)
Figure France Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure France Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2022-2027)
Figure UK Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure UK Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2022-2027)
Figure Russia Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure Russia Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2022-2027)
Figure Italy Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure Italy Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2022-2027)
Figure Rest of Europe Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure Rest of Europe Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2022-2027)
Figure Asia-Pacific Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure Asia-Pacific Sickle Cell Anemia Testing And Screening Market and Growth Rate (2022-2027)
Figure Asia-Pacific Sickle Cell Anemia Testing And Screening by Country (2022-2027)
Figure Asia-Pacific Sickle Cell Anemia Testing And Screening Revenue (Million USD) by Country (2022-2027)
Figure China Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure China Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2022-2027)
Figure Japan Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure Japan Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2022-2027)
Figure Korea Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure Korea Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2022-2027)
Figure India Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure India Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2022-2027)
Figure Southeast Asia Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure Southeast Asia Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2022-2027)
Figure Rest of Asia-Pacific Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure Rest of Asia-Pacific Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2022-2027)
Figure South America Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure South America Sickle Cell Anemia Testing And Screening Market and Growth Rate (2022-2027)
Figure South America Sickle Cell Anemia Testing And Screening by Country (2022-2027)
Figure South America Sickle Cell Anemia Testing And Screening Revenue (Million USD) by Country (2022-2027)
Figure Brazil Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure Brazil Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2022-2027)
Figure Mexico Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure Mexico Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2022-2027)
Figure Columbia Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure Columbia Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2022-2027)
Figure Rest of South America Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure Rest of South America Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2022-2027)
Figure Middle East and Africa Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure Middle East and Africa Sickle Cell Anemia Testing And Screening Market and Growth Rate (2022-2027)
Figure Middle East and Africa Sickle Cell Anemia Testing And Screening by Country (2022-2027)
Figure Middle East and Africa Sickle Cell Anemia Testing And Screening Revenue (Million USD) by Country (2022-2027)
Figure Saudi Arabia Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure Saudi Arabia Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2022-2027)
Figure United Arab Emirates Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure United Arab Emirates Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2022-2027)
Figure South Africa Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure South Africa Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2022-2027)
Figure Rest of Middle East and Africa Sickle Cell Anemia Testing And Screening Growth Rate (2022-2027)
Figure Rest of Middle East and Africa Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2022-2027)
Table HemoTypeSC Sickle Cell Anemia Testing And Screening Financial Overview
Table Halcyon Biomedical, Inc. Sickle Cell Anemia Testing And Screening Financial Overview
Table Request A Test, Ltd Sickle Cell Anemia Testing And Screening Financial Overview
Table Daktari Diagnostics Sickle Cell Anemia Testing And Screening Financial Overview
Table Streck, Inc. Sickle Cell Anemia Testing And Screening Financial Overview
Table Bio-Rad Laboratories, Inc Sickle Cell Anemia Testing And Screening Financial Overview
Table Hemex Health Sickle Cell Anemia Testing And Screening Financial Overview
Table Silver Lake Research Corporation Sickle Cell Anemia Testing And Screening Financial Overview
Table BioMedomics Inc. Sickle Cell Anemia Testing And Screening Financial Overview
Table Laboratory Corporation of America Holdings Sickle Cell Anemia Testing And Screening Financial Overview
Figure Sickle Cell Anemia Testing And Screening Revenue (Millions USD) and Growth Rate (2021-2027)
Table Sickle Cell Anemia Testing And Screening Market Forecast by Regions (2021-2027)
Figure Sickle Cell Anemia Testing And Screening Forecast by Technologies (2021-2027)
Figure Sickle Cell Anemia Testing And Screening Market Share Forecast by Technologies (2021-2027)
Figure Sickle Cell Anemia Testing And Screening Forecast by Technologies (2021-2027)
Figure Sickle Cell Anemia Testing And Screening Forecast by Age Groups (2021-2027)
Figure Sickle Cell Anemia Testing And Screening Market Share Forecast by Age Groups (2021-2027)
Figure Sickle Cell Anemia Testing And Screening Forecast by Age Groups (2021-2027)
Figure Sickle Cell Anemia Testing And Screening Forecast by Sector Type (2021-2027)
Figure Sickle Cell Anemia Testing And Screening Market Share Forecast by Sector Type (2021-2027)
Figure Sickle Cell Anemia Testing And Screening Forecast by Sector Type (2021-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2027) |
|
|